Research and Development

The Research and Development team at ISA Pharmaceuticals focuses on the innovation and refinement of synthetic immunotherapeutics targeting cancer and viral infections. Led by experts in chemistry and immunology, the team is responsible for designing and advancing the Synthetic Long Peptide (SLP®) platform and AMPLIVANT® technology, while ensuring compliance with regulatory standards through CMC (Chemistry, Manufacturing, and Controls) oversight. Their collaborative efforts aim to translate scientific discoveries into effective therapeutic solutions.